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I. lntroduction
1.1. Pathophysiology
Tuberculosis (TB) has troubled humankind throughout history. It has been a leading 
cause of death throughout the world, and still is in low- and middle-income countries. TB 
is a classic example of airbome infection. Bacilli that reach the respiratory bronchioles 
and alveoli are generally ingested by alveolar macrophages and removed fforn the alveoli. 
Macrophages, even in individuals with no prior immunologic experience with 
mycobacterial infection, possess somé bacterial-killing or growth-inhibitory capability. 
Thus, killing and digestion of the organism probably follow in the majority of exposures 
to Mycobacterium tuberculosis. However, when many droplet nuclei containmg tubercle 
bacilli reach the alveoli, the number of bacilli ingested by an individual macrophage can 
overwhelm the microbicidal system of the phagocyte. When the nonspccific defences are 
insufficient to kill all of the organisms, the surviving bacilli multiply, causing a localized 
tuberculous pneumonia In generál, in the presence of an effective, specific cell-mediated 
immuné response, this lesion heals spontaneously, leaving only a calcified focus (Ghon 
lesion), which may be accompanied by calcification in hilar nodes, the two lesions 
together forming the Ranke complex.
The principal immuné response associated with protection against tuberculosis is 
cell-mediated immunity involving T lymphocytes and macrophages. Although 
immunization does nőt prevent infection with M. tuberculosis, the growth of the organism 
within macrophages is reduced by several orders of magnitude. In dramatic contrast, 
immunodeficiency, such as that produced by Humán Immunodeficiency Virus (HÍV) 
infection or selective depletion of T cells or cytokines, especially interferon-y (IFN-y), 
results in a weakening of defences against M. tuberculosis. However, because M. 
tuberculosis is a virulent organism, little if any immunodeficiency is necessary fór disease 
development. Thus, TB, which commonly occurs with a lesser degree of 
immunodeficiency than other HIV-associated infections, has become a sentinel disease 
fór the presence of HÍV infection.
1.2. Epidemiology
TB is a major threat to global health, recently exacerbated by the emergence of 
highly drug-resistant forms of the disease-causing pathogen and synergy with HÍV / 
AIDS (Acquired Immunodeficiency Syndrome) A recent report on the TB pandemic 
revealed that in 2005, there were almost 9 millión new cases and 1.6 millión deaths.
2Unfortunately, it has been estimated that one third of the world ’s population is latently 
infected with M tuberculosis, providing an enormous reservoir fór future disease.
1.3. Tuberculosis control
The Stop TB (S TB) Partnership’s goal is eliminating TB as a public health problem 
by 2050. However, the cunent tools fór diagnosing, treating, and preventing TB are 
inadequate fór this task: latent and active TB are most commonly diagnosed using, 
respectively, a skin test that dates back to 1891 and sputum-smear microscopy from the 
same éra. Despite its widespread use, the BCG vaccine is largely ineffective, at least in 
preventing aduit pulmonary disease. Conventional short-course therapy has nőt changed 
fór decades. The most frequently recommended and effective combination is isoniazid, 
rifampicin, pyrazinamide, and ethambutol fór 2 months, followed by isoniazid and 
rifampicin fór 4 months. This régimén is very effective fór treatment of patients with TB, 
including those with HÍV infection. Failure to complete therapy is associated with 
longlasting infectious status, relapse, and drug resistance. Unfortunately, acquired 
rifamycin resistance has arisen in HIV-infected individuals and in those with widespread 
disease. A growing problem that has had an impact on the success of treatment programs 
is the emergence of strains of multidrug-resistant TB (MDR-TB), which is defined as 
resistance to isoniazid and rifampicin, to the drugs used as first-line treatment. Around 
400,000 cases of multidrug- resistant M. tuberculosis infection occur per year.
Furthermore, essentially untreatable outbreaks of extensively drug-resistant TB 
(XDR-TB) have begun to appear. XDR-TB is defined as MDR-TB plus resistance to a 
quinolone and one of the second-line anti-TB injectable drugs (Amikacin, Kanamycin, 
and Capreomycin).
New antituberculotic drugs are needed to improve the treatment of patients with 
multidrug-resistant TB, and might enable the duration of treatment to be shortened.
1.4. The importance of RNA metabolism
M. tuberculosis can survive and even replicate in naive macrophages and thus must 
assimilate carbon and produce energy in the phagosome. M. tuberculosis is among the 
most successfiil microorganisms that adapt to long-term residence in macrophage 
phagosomes. Adaptive intracellular gene expression involves genes that are associated 
with virulence, the generál stress response, changes in cell wall structure and alternative- 
carbon-source utilization pathways and their reguládon. The tumover of mRNA plays an 
important role in the regulation of gene expression.
3In E coli, a key enzyme of RNA decay is RNase E. It is an essential enzyme, 
responsible fór the initial ratelimiting cleavage in the decay of many mRNAs, as well as 
playing an important role in 5S and 16S rRNA processing.
In our laboratory in accordance with other researchers, we believe that RNase E the 
main enzyme of RNA metabolism is a potential target of drug aiming.
1.5. RNase E and the degradosome it organises
RNase E was originally discovered as an RNA processing enzyme. Later it was 
found that its gene, rne, and ams (altered messenger stability) are identical, suggesting a 
key role fór RNase E in bacterial RNA processing and decay. Subsequent studies revealed 
that RNase E Controls the stability of many, if nőt the most, mRNAs in t .  coli as well as 
being involved in the processing of tRNA precursors and degradation of small regulatory 
RNAs. Moreover, RNase E has the ability to affect protein degradation through its role in 
maturation of the 3’ end of tmRNA (SsrA).
Our current knowledge about this enzyme mainly originates from studies of E. coli 
RNase E, which is a site-specific ribonuclease that preferentially cleaves in A/U-rich 
single-stranded regions of structured RNAs.
E. coli RNase E is indispensable fór cell viability. Structural data obtained fór an N- 
terminal polypeptide representing the evolutionarily conserved catalytic domain of this 
protein have revealed the presence of discrete folds with putative functions in RNA 
recognition and cleavage. Moreover, these data and others indicate that the catalytic 
domain exists as a homotetramer, which has two non-equivalent subunit interfaces 
organizing the active site of the enzyme. In contrast with the N-terminal catalytic domain, 
the C-terminál part of E. coli RNase E shows very little or no similarity to the equivalent 
regions of other RNase E homologues. This part of the E. coli enzyme contains an extra 
RNA-binding domain(s) and multiple sites fór interactions with the 3' to 5’ 
phosphorolytic cxonuclease PNPase (polynucleotide phosphorylase), the RNA helicase 
RhlB and the glycolytic enzyme enolase to form the E coli multienzyme complex 
referred to as 'degradosome'. Interestingly the RNA degradosome protems comprise parts 
of the bacterial cytoskeleton.
E. coli RNase G is encoded by the mg  gene and was initially termed CafA owing to 
its effects on the formation of cytoplasmic axial filaments observed upon RNase G 
overproduction in vivő. Further studies have revealed that this protein has an 
endoribonucleolytic activity and is involved in maturation of 16S rRNA in vivő. Although 
RNase G functionally overlaps with RNase F. and shares 35% identity with and 50%
4similarity to the N-terminal catalytic part of RNase E, this endoribonuclease cannol fully 
cornpensate RNase E deficiency in rne" mutant strains.
Owing to their overlapping functions and apparently comraon origin, RNase E- and 
RNase G-like proteins are believed to belong to the same family of RNase E/G 
endoribonucleases that are predicted to exist in many bacteria, including pathogenic 
species. Although their biochemical properties and biological functions have nőt yet been 
investigated in detail in humán pathogens, such studies can offer important insights 
conceming the role of these endoribonucleases during infection and disease development. 
Recent results demonstrated the importance of RNase E in bacterial pathogenicity. In 
yersinia, the RNase E activity impacts the Type Three Secretion System and plays a 
generál role in infectivity. Magnesium homeostasis is very important fór the intracellular 
survival of salmonella. The Mg2’ riboswiteh targets the mgtA transcript fór the 
degradation by RNase E when cells are grown in high Mg2’ environments.
Given the central role of RNase E in RNA Processing and decay in E. coli, it is 
conceivable that RNase E-dependent regulation of RNA stability in mycobacteria might 
alsó represent a very important mechanism adjusting the cellular metabolism to 
environmental changes. These considerations prompted us to purify and characterize the 
RNase E/G homologue (RNase E/G) írom the intracellular pathogen M tuberculosis.
The difference between pathogenic and saprophytic mycobacteria on the level of 
RNA metabolism is yet nőt known.
II. Aims
To leam more about RNase E proteins that fiinction in different mycobacterial 
species, we cloned, overexpressed and purified putative mycobacterial RNase E/G 
homologues from M bovis BCG, írom M. tuberculosis and M. smegmatis.
I. The present study was designed to identify proteins associated with RNase E from:
a. M. tuberculosis 
b M. smegmatis
II. Biochemical characterisation of RNase E/G from M. tuberculosis.
a. To study the 5'-end-dependence of this endoribonuclease 
b To examine the quatemary structure of the mycobacterial RNase E 
c. To study if it can cleave a putative 5S rRNA precursor in vitro 
d To compare its substrate specificity to the E coli counterpart
5III. Materials and methods
III. 1. Bacterial strains and growth conditions
E. coli DH5a, E coli HB101, E. coli BL21 (DE3) and E. coli BL21-CodonPlus 
(DE3)-RIL strains were routinely grown in LB (Luria Bertani) médium supplemented 
with the appropriate antibiotic(s). M. bovis BCG was grown in Middlebrook 7H9 broth or 
7H11 agar (Difco). M smegmatis MC2 155 was grown either in Middlebrook or in LB 
médium.
III.2. Cloning of mycobacterial RNase E, RNase E/G and Srne
The DNA fragment containing the corresponding gene was amphfied by PCR, using 
conditions recommended by the manufacturer. The amplified DNA was inserted intő 
p6HisF-lld(/c/). The resulting plasmid was used to overexpress RNase E in E. coli. 
pőHisFl ld(í'c() is a pET-1 ld (Novagen) based plasmid carrying the 6His and FLAG tags 
in the N-terminal of the cloned insert.
H U . Expression of the mycobacterial proteins (RNase E, RNase E/G and Srne) in E. 
coli
Fór overexpression, E. coli HB101(pGPl-4) cells carrying the proper plasmid were 
grown and treated according to the method of Tábor and Richardson. 
m .4. Expression of the mycobacterial proteins (RNase E, RNase E/G) in M. bovis 
BCG or Srne in M. smegmatis MC2 155
pET plasmids cannot be used in mycobacteria, fór this purpose we created new 
constructs using pMV262 shuttle plasmid. These plasmids as well as pMV262(ír/) coding 
fór isocitrate lyase (lel) were transformed to M bovis BCG, or in case of MSMEG 4626 
to M. smegmatis by eleetroporation.
III.5. Purification of RNase E, RNase E/G, Srne and lel
Bacteria were opened in a MiniBeadbeater-8 cell disrupter (BioSpec Products, Inc, 
Barlesville, Oklahoma), using glass beads (106 pm, Sigma) and adding a protease 
inhibitor cocktail (Sigma). Proteins were purified either on an anti-FLAG M2 affmity gél 
(Sigma), or by using Talon Metál Affmity Resin (BD Biosciences) according to the 
manufacturer’s instructions.
III. 6. Identification of protein bands
The gél slices containing the corresponding polypeptides were cut from the gél and 
analyzed by mass speetrometry (Biological Research Centre, Szeged). Post source decay 
analysis was used to confirm the MALDI-TOF results.
6111.7. Purification of Rne498
E. coli BL2I(DE3) strain was used to overexpress 6His-tagged Rne498, and the 
overexpressed protein was purified using immobilized metal-affínity chromatography as 
described previously.
111.8. Purification of M. tuberculosis RNase E/G fór biochemical characterisation
The pMRGl construct, verified by sequencing was transformed intő the E. coli strain 
BL21-CodonPlus (DE3)-RIL. The cells were dismpted by sonication in a Cell Disruptor 
W375 (Heat Systems Ultrasonics), and the supematant was applied to a HisTrap HP 
(Amersham Biosciences) column to purify 6His-tagged RNase E/G according to the 
manufacturer's instructions.
111.9. In vitro transcription and iabelling of 9S RNA
A DNA fragment including the putative M. bovis BCG 9S RNA sequence was PCR- 
amplifted from genomic DNA and cloned intő the pGEM®-T Easy vector (Promega) at 
the T cloning site. The resulting plasmid (pMt9S) was used to transcribe 9S RNA with a 
MEGAscript® T7 kit (Ambion). 9S RNA was 5-labelled using T4 polynucleotide 
phosphorylase (Fermentas) and an excess of [y-32P]ATP (Amersham Biosciences) and 
subsequently used fór cleavage assays.
111.10. Primer extension
Totál RNA ffom M. bovis BCG was extracted using the hot phenol method. The 5’- 
32P-labelled 5S rRNA-speciftc oligonucleotide 5SPEM (5'- 
CAGTATCATCGGCGCTGGC-3') and totál RNA were mixed with 5 pl of RT buffer 
containing 4 units of AMV reverse transcriptase (Promega). The reaction was stopped by 
adding 10 pl of sequencing dye. The sample was analysed on an 8% sequencing gél along 
with a concurrently run sequencing ladder.
111.11. Synthetic oligonucleotide substrates
Ribo-oligonucleotides (BR10), (9SA), (OtnpC), (A27), (U27), (U27G), (U27A) and 
(U27C), as well as oligonucleotides (pBR13-Fluor) and (HO-BR13-Fluor) with a 
fluorescein tag at their 3’ ends, were purchased from VBC Genomics, whereas (U27ab) 
containing an abasic residue (X) was purchased from Dharmacon.
111.12. RNase E/G cleavage of oligonucleotide substrates and 9S RNA
RNase E/G cleavage reactions were performed as described previously using Rne498 
or RNase E/G and 5'-labelled substrates. Ladders (1 nt) were prepared either by partial 
alkaline hydrolysis, or by partial digestion of each 5'-end-labelled oligonucleotides with 
SÍ nuclease or with RNase Ti.
7IV. Results
IV. 1. Expression of RNase E írom M. tuberculosis
It is a protein consisting of 953 amino acids. Its calculated molecular mass is 103 
kDa, bút in SDS polyacryiamide gels it migrates as a 150 kDa protein. M. tuberculosis 
H37Rv RNase E displays 100% identity with the full-length M. bovis BCG RNase E.
IV. 2. Expression of M. smegmatis Srne
Sme is consisting of 1037 amino acids. Its calculated molecular weight is 112.7 kDa; 
because of the 6His and FLAG tags, our fusion protein is 4 kDa larger. In SDS- 
polyacrylamide gels it migrates as a 180 kDa protein.
IV. 3. Associated proteins to RNase E front M. tuberculosis
RNase E was overexpressed in different bacterial hosts and affínity-purified. Despite 
the use of protease inhibitors, in addition to the full-length polypeptide, the mycobacterial 
preparation from E. coli alsó contained its proteolytic forms. DnaK is among the 
identified copurified proteins. DnaK is involved in many cellular activities, including the 
heat shock response. Further associated proteins were lipoamide dehydrogenase (NADH), 
a component of 2-oxodehydrogenase and pyruvate complexes and a mixture of ribosomal 
proteins L1 (B3984) and S2 (B0169).
In the RNase E preparation isolated from M. bovis BCG, GroEL was identified. This 
is a chaperonin mediating protein folding and assembly. The preparation contained 
furthermore the products of genes Mbl721 and Mb0825c, respectively. These proteins 
were found in the database as hypothetical proteins. Mbl721 is equivalent to Rvl695 
(100 % identity) from M. tuberculosis H37Rv. Gene MTI734 from M tuberculosis 
CDC1551 codes fór the same protein. This protein is an inorganic polyphosphate/ATP- 
NAD kinase (Ppnk). Mb0825c is equivalent to Rv0802c and MT0822 from M. 
tuberculosis H37Rv and CDC1551, respectively. The protein displays partial similarity 
with many acetyltransferases and hypothetical proteins. Table I lists the identified 
proteins and the comparison of the RNase E associated proteins from different bacteria. 
IV. 4. Srne-associated proteins
Table I lists the identified proteins. Proteolytic fragments of RNase E were found in 
all bands checked. GroL was the major associated protein. However ribosomal proteins 
were alsó present. Among others, a negative regulator of genetic competence and a 
GTP pyrophosphokinase, which has role in cellular response to starvation.
8dimethyladenosine transferase and the universal stress protein were alsó component of the 
complex.
No visible differences were seen in the associated proteins when M. smegmatis was 
grown in LB or in Middlebrook média.
E. coli M. tuberculosis RNase E in M. bovis BCG M. smegmatis
• Polynucleotide
phosphorylase • GroEL
• Inorganic polyphosphate/ATP-NAD kinase
• Chaperonin GroL
• Enolase (Mbl721) • Ribosomal proteins
• Negative regulator of
• Rh 1B helicase • N-acetyltransferase (Mb0825c) genetic competence
• GTP pyrophosphokinase
• Proteosome component
• EFTu
Table I.: Comparison of the RNase E associated proteins írom different bacteria
IV. 5. Expression and purification of mycobacterial RNase E/G
In M. tuberculosis CDC1551, RNase E/G contains 661 amino acids and exhibits 
100% identity with the C-terminal part of H37Rv RNase E. This polypeptide with the 
predicted molecular weight of 67 kDa, has an aberrant mobility (100 kDa) in SDS 
polyacrylamide gels. Likewise, its overexpression in M. bovis BCG and purification 
results in a preparation that contains a copurified inorganic polyphosphate/ATP-NAD 
kinase (Ppnk), a truncated form of RNaseE/G and an extra polypeptide, whose identity 
was nőt determined.
IV. 6. Expression and purification of mycobacterial RNase E/G fór biochemical 
characterisation
The71 kDa RNase E/G fforn the M tuberculosis exhibited an aberrant mobility, 
migrating as a 110 kDa polypeptide. Mass spectrometry analysis did nőt reveal any 
contamination of the RNase E/G preparation by E. coli RNase E/G polypeptides or other 
hőst ribonucleases.
IV. 7. Quaternary structure of M. tuberculosis RNase E/G
RNase E was eluted as a complex with a hydrodynamic radius corresponding to a 
spherical protein with an apparent molecular mass of approx. 325 kDa, suggesting that, it 
may exist in a tetrameric form.
9IV. 8. Cleavage of oligonucleotide substrates
RNase E/G could cut BR10, 9SA and OmpC yielding cleavage pattems that were 
largely indistinguishable írom the analogous pattems generated by its E. coli counterpart. 
A minor difference was only observed in the cleavage pattem of OmpC. Although 
Rne498 cleaved this oligonucleotide at positions 5 and 6 with equal efficiencies, RNase 
E/G showed somé preference fór cleavage at position 5. We alsó found that, similar to its 
RNase E/G homologues from Aquifex aeolicus and E. coli, RNase E/G requires Mg2+ ions 
fór its activity.
IV. 9. 5'-end-dependence of M. tuberculosis RNase E/G cleavages
RNase E/G cleaves 5’-monophosphorylated substrates faster than the non- 
phosphorylated ones.
IV. 10. Probing the substrate specificity of M. tuberculosis RNase E/G
In order to identiíy specific sequence determinants of RNase E/G cleavage sites, we 
used the same oligonucleotide-based approach that was employed previously to 
characterize its E. coli counterpart. By comparing the cleavage pattems of po!y(A) and 
poly(U) oligonucleotides and their mutant variants carrying single-base substitutions of 
G, C, U or A respectively fór adenosine (or uridine), this method allows determination of 
each nucleotide’s effect at multipie positions to the point of cleavage. Unlike E. coli 
RNase E, RNase E/G cleaved A27 inefficiently. In the following assays, we therefore 
decided to use only U27 (control) and its derivatives, U27A, U27G, U27C and U27ab 
oligonucleotides, that had a single-base substitution of A, G, C or abasic residue 
respectively fór U at position 14. Similar to cleavage of U27, incubation of U27G with 
RNase E/G and Rne498 resulted in nearly identical pattems. The major cleavages of 
U27G at positions U8, U9, U10 and U15 were observed fór both enzymes, whereas 
Rne498 (bút nőt RNase E/G) could additionally cleave this substrate at position U18. In 
the case of E. coli RNase E, it has been reported previously that a G nucleotide, which is 
5' and in close vicinity to the scissile bond, is an important determinant of cleavage. 
Likewise, we found that M. tuberculosis RNase E/G cleavage is more efficient if there is 
a G nucleotide located two nucleotides upstream of the scissile bond. These data are fully 
consistent with the cleavage pattems of BR10, 9SA and OmpC oligonucleotides, showing 
that RNase E/G cleavage frequently occurs two nucleotides downstream of a G 
nucleotide.
In contrast with nearly identical cleavage pattems that were generated by RNase E/G 
and Rne498 using U27G, the cleavage pattems of U27A, U27C and U27ab showed
10
relatively low resemblance. Although Rne498 can cut at multiple positions within U27A, 
RNase E/G cleavage of the same substrate was nőt observed at many of these locations, 
especially downstream and upstream of U16. Similarly, the presence of a cytosine at 
position 14 in U27C strongly inhibits RNase E/G cleavage at nearly all locations, 
suggesting the overall inhibiting effect of this nucleotide.
Finally, we found that substitution of an abasic residue fór the U at position 14 in 
U27ab decreased the effíciency of RNase E/G cleavage at multiple locations. This finding 
strongly suggests that the presence of uridines at many locations close to the scissile bond 
promotes RNase E/G cleavage. On the basis of the above experimental data, we 
determined and summarized the effects of each nucleotide within RNase E/G cleavage 
sites Interestingly, according to these data, the C at position +2 in 9SA should confer 
higher resistance of this oligonucleotide (in comparison with BR10 lacking a cytosine at 
the equivalent position) to RNase E/G. In contrast, we did nőt observe any significant 
differences in the effíciency of cleavage. This may imply that the expected inhibiting 
effect of the cytosine was efficiently counteracted by other nucleotides, fór example by 
the A and G nucleotides at positions -3  and -2  respectively. In other words, strong 
enhancing effects of nucleotides at certain positions of different cleavage sites can 
potentially neutralize or override negative effects of other sequence determinants, 
resultíng in approximately equal effíciency of cleavage. As in the case of E. coli RNase E, 
the effíciency of RNase E/G cleavage of U27 and its mutant variants decreases with the 
number of the remaining nucleotides that are 5' to the scissile bond (the ‘end-proximity 
effect’), thereby leading to accumulation of short oligomers that are further resistant to 
the nucleolytic activity of this enzyme.
IV. 11. 9S RNA processing by M. tuberculosis RNase E/G
Although both Rne498 and RNase E/G could cleave M tuberculosis 9S RNA, the 
cleavages occurred at different locations. Further analysis revealed that RNase E/G 
cleaved 9S RNA at the position, which nearly coincides with the position of the 5’-end of 
mature 5S rRNA in vivő, which was mapped by primer extension of totál RNA.
V.Discussion
It has been more than 30 years since the introduction of a növel compound fór the 
treatment of tuberculosis. New drugs are extremely needed. Agents that reduce the 
duration and complexity of the current therapy would have a major impact on compliance 
and overall cure rate. In recent years. our understanding of the tubcrcle bacillus and its
interaction with the humán hőst has improved dramatically, particularly with the 
publication in 1998 of the complete genome sequence of M tuherculosis H37Rv. New 
genetic tools have been developed and we can now ascertain the function of individual 
genes. Thus, many potential drug targets can be identified.
Mycobacteria are very successful pathogens, which are able to survive under adverse 
conditions like long non-replicating persistence, intracellular survival. Dynamic 
regulation of RNA decay and processing should be a very important factor in adapting to 
environmental changes. Over the pást years it became obvious that mRNA degradation is 
a very important step in regulation of prokaryotic gene expression.
Given the Central role of RNase E in RNA processing and decay in E. coli, it is 
conceivable that the RNase E-dependent regulation of RNA stability in mycobacteria 
might alsó be a very important mechanism, adjusting the ceilular metabolism to 
environmental changes. Adaptive processes in the RNA metabolism of latent 
mycobacteria differentially affect the steady-state levels of numerous transcripts, 
ribosome biosynthesis as well as RNase E/G levels, suggesting an important regulatory 
role of this enzyme during disease development.
We focus our work on mycobacterial RNase E like proteins; the results are the first 
steps towards understanding their structure, function and the role of bacterial metabolism.
Although M. tuherculosis and related species are considered to be members of Gram 
positive bacteria, the mechanisms of RNA decay and processing in these organisms are 
apparently different from the regulatory circuits that control RNA metabolism in Gram 
positive bacteria with a low GC content such as Bacillus subtilis. The latter lacks 
RNase E and RNase G (CafA) and therefore the mechanisms that regulate RNA stability 
in B. subtilis must be quite different ffom those taking piacé in mycobacteria. On the 
other hand, RNase E can be found in the majority of humán pathogens (both Gram 
positive and Gram negative bacteria), where it seems to be a key enzyme in RNA 
processing and degradation.
In our work we cloned, expressed and purified the RNase E/G homologue from 
M tuherculosis (RNase E) and M. smegmatis (Sme) and identified associated proteins. 
RNase E and RNA hehcase B play Central roles in the cytoskeletal orgamzation of the 
degradosome in E. coli. Polynucleotide phosphorylase and enolase are alsó important 
components. In agreement with a previously proposed idea, the associated proteins can be 
different in other bacteria.
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In M. tuberculosis RNase E preparation from E. coli DnaK was identified. This 
polypeptide was previously found in the preparations when E. coli RNase E was 
overexpressed upon temperature-induced induction. It was nőt found in the RNase E 
complex, when RNase E was isolated without overexpression. In a DnaK(-) background, 
in an expenment, where the role of molecular chaperones in inclusion body formation 
was studied, the amount of inclusion body protein was 2.5-fold higher, than in the wild- 
type strain. In the preparation isolated from M. bovis BCG, GroEL, the products of genes 
Mbl721 (Ppnk) and Mb0825c were identified. Rvl695 (equivalent to MbI721) has been 
cloned and expressed in E. coli. Ppnk catalyzes the reaction leading to the formation of 
NADP by the use of ATP or inorganic polyphosphate, playing a crucial role in the 
regulation of NAD/NADP level and in biosynthetic reactions in the cell. Its association 
with RNase E may play a regulatory role by helping to adapt to environmental changes. 
When 6-His-tag labellcd proteins from lysates of M. smegmatis were purified alsó GroL 
was the major associated protein. The copurified proteins from M. smegmatis were 
different from those in E. coli, as expected after previous mycobacterial studies, though 
surprisingly they were nőt even identical to the associated proteins we found in case of 
the RNase E/G homologue from M. tuberculosis. Interestingly much more proteins were 
detected in the M. smegmatis preparations, than in the ones from M. tuberculosis. 
Although it is nőt easy to determine whether the associated proteins we report from M. 
smegmatis are specific functional components or occasional contaminants, it is important 
to note that the overexpression and subsequent purification of isocitrate lyase has yielded 
nearly pure recombinant protein, indicating that the above desoribed copurification is 
specific and is nőt dependent on the presence of the 6HisFLAG tag.
While there is strong homology in the catalytic part of RNase E enzymes among 
mycobacteria, the C-terminal portions are quite different In silico, using the CLC 
Combined Workbench the secondary structure of the RNase E from M smegmatis and 
M. tuberculosis was drawn. Srne is mostly helical protein, containing 30 a-helices and 
with Pfam anaiysis 22 potential domains were suggested, with 9 domains more, than what 
was predicted in the tuberculosis RNase E. The in silico results suggest that there are 
possible differences among mycobacteria in the structure of the enzyme, which could 
explain the difference in quality and quantity of the associated proteins.
Despite the use of protease inhibitors in addition to the full-length RNase E its 
proteolytic fragments were detected in all bands. E. coli RNase E is alsó very sensilive to 
proteolysis. The presence of PNPase and RhlB helicase could nőt be detected among the
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copurified proteins. The M. smegmatis genome contains genes coding fór PNPase 
(MSMF.G 2656) and RhlB helicase (MSMEG_1930). The proteins we found as 
associated proteins take part in protein synthesis, reguládon and the stress response.
Our data indicate that, similar to E. coli, mycobacterial RNase E/G homologues are 
able to copurify with other proteins. However, in agreement with the previously proposed 
idea, the natúré of the associated proteins is different when compared to the composition 
of the E. coli RNase E complex. Further studies are needed to address the role of the 
identified proteins in relation to the specific steps of RNA metabolism in mycobacteria 
and their regulation by environmental factors.
To leam more about the fiinction and biochemical properties of the RNase E/G 
homologue from M. tuberculosis (RNase E/G), we cloned, purified and characterized a 
polypeptide including the centrally located catalytic domain as well as the flanking C- 
terminal part of this protein, since the full-length M. tuberculosis RNase E is difiiéül! to 
purify in large amounts because of its tendency to form insoluble aggregates upon 
overexpression.
RNase E/G homologues from Gram-negative bacteria are known to preferentially 
cleave 5'-monophosphorylated substrates over non-phosphorylated or 
5'-triphosphorylated ones. By employing oligonucleotide substrates, we have alsó shown 
that RNase E/G has an endoribonucleolytic activity, which is dependent on the 5'- 
phosphorylation status of its substrates, thereby suggesting that RNase E/G is a 5'-end- 
dependent endoribonuclease. Thus our fmdings suggest that the so-called 5 -end- 
dependence is apparently a common feature of RNase E/G homologues from both Gram- 
negative and Gram-positive bacteria. This property of RNase E/G and other RNase E/G 
homologues implies that these enzymes more efficiently cleave already damaged or 
partially degraded forms of cellular RNAs (i.e. RNA species that usually carry 5'- 
monophosphate groups) rather than primary transcripts, which are namrally 
triphosphorylated.
Given that RNase E and RNase G are involved in maturation of ribosomal and 
transfer RNAs in E. coli, we anticipated that this function of RNase E/G-like proteins 
might be alsó conserved in mycobacteria. Indeed, we found that RNase E/G was able to 
cleave mycobacterial 9S RNA, a putative precursor of its cognate 5S rRNA, and the 
cleavage occurred in close vicinity to the mature 5'-end of 5S rRNA, thereby suggesting a 
role fór this enzyme in rRNA processing. Although the internucleotide bonds at the 5'-end 
of 5S rRNA that are generated by RNase E/G in vitro and during rRNA processing in vivő
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were nőt exactly the same, this minor (one or two nucleotide) difference could be well 
explained by the action of ancilliary factors or associated lábosomat proteins that can 
affect RNase E/G cleavage in vivő and therefore slightly influence the selection of the 
scissile bond(s).
Taken together, our findings expand the current knowledge about complexforming 
and biochemical characteristics of RNase E/G enzymes and provide a basis fór further 
analysis of their putative functions in mycobacteria.
VI. Conclusions
TB is a major threat to global health, recently exacerbated by the emergence of 
highly drug-resistant forms of the disease-causing pathogen and synergy with HÍV / 
AIDS New antituberculotic drugs are needed to improve the treatment of patients with 
multidrug-resistant TB, and they might enable the duration of treatment to be shortened.
Mycobacteria are very successful pathogens; they are able to survive under adverse 
conditions. Dynamic regulation of RNA decay and Processing should be a very important 
factor in adapting to environmenta! changes. Over the pást years it became obvious that 
mRNA stability is a very important step in regulation of prokaryotic gene expression.
Given the Central role of RNase E in RNA Processing and decay in E. coli and other 
bacteria, it is conceivable that the RNase E-dependent regulation of RNA stability in 
mycobacteria might alsó be a very important mechanism, adjusting the cellular 
metabolism to environmental changes.
We focus our work on mycobacterial RNase E like proteins. We cloned RNase E 
(rom M tuberculosis, M. bovis BCG and M. smegmatis, expressed and purified the 
proteins, identified associated proteins and characterised enzyme activities. Our results 
are (he first steps towards the understanding of RNA metabolism in mycobacteria and 
could make fínding new drug targets possible. Further studies are needed to address the 
speciftc roles of the associated proteins in relations to the specific steps of RNA 
metabolism in mycobacteria and their regulation by environmental factors.
VII. New statements of the thesis
• RNase E was cloned fór the first time írom M. tuberculosis, M. bovis BCG and M
smegmatis.
• We were the first to express and to purify these proteins and alsó to identify the
associated proteins in mycobacteria.
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• It was published fór the first time, that the RNase E/G homologue from M 
tuberculosis has enzymatic activity and we characterised the enzyme activities.
• We were the first to show that RNase E/G was able to cleave mycobacterial 9S RNA, 
a putative precursor of its cognate SS rRNA.
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